<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100886721</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21363</journal-id>
<journal-id journal-id-type="nlm-ta">BJU Int</journal-id>
<journal-id journal-id-type="iso-abbrev">BJU Int.</journal-id>
<journal-title-group>
<journal-title>BJU international</journal-title>
</journal-title-group>
<issn pub-type="ppub">1464-4096</issn>
<issn pub-type="epub">1464-410X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30113772</article-id>
<article-id pub-id-type="pmc">7368761</article-id>
<article-id pub-id-type="doi">10.1111/bju.14524</article-id>
<article-id pub-id-type="manuscript">NIHMS1001733</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Phenotypic Severity Scoring System and Categorization for Prune Belly Syndrome: Application to a Pilot Cohort of 50 Living Patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wong</surname>
<given-names>DG</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arevalo</surname>
<given-names>MK</given-names>
</name>
<email>michelle.arevalo@utsouthwestern.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Passoni</surname>
<given-names>NM</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iqbal</surname>
<given-names>NS</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jascur</surname>
<given-names>T</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kern</surname>
<given-names>AJ</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanchez</surname>
<given-names>EJ</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Satyanarayan</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gattineni</surname>
<given-names>J</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>LA</given-names>
</name>
<email>linda.baker@childrens.com</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA</aff>
<aff id="A2"><label>2</label>Pediatric Urology, Anne Arundel Medical Center, 2001 Medical Pkwy, Annapolis, MD 21401, USA</aff>
<aff id="A3"><label>3</label>Pediatric Nephrology, Children’s Health Dallas, 1935 Medical District Dr, Suite B5238, Dallas, TX 75235, USA</aff>
<aff id="A4"><label>4</label>Pediatric Urology, Children’s Health Dallas, 2350 N. Stemmons Freeway, Suite F4300, Dallas, TX 75207, USA</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding author. M.K. Arevalo, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA, Tel.: +1 314 807 1271; fax.: +1 214 648 3800</corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P34">Conflict of Interest Statement</p>
<p id="P35">None.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>123</volume>
<issue>1</issue>
<fpage>130</fpage>
<lpage>139</lpage>
<!--elocation-id from pubmed: 10.1111/bju.14524-->
<abstract id="ABS1">
<sec id="S1">
<title>OBJECTIVE:</title>
<p id="P1">To design a novel system of scoring Prune Belly Syndrome (PBS) phenotypic severity at any presenting age and apply it to a large pilot cohort.</p>
</sec>
<sec id="S2">
<title>PATIENTS AND METHODS:</title>
<p id="P2">From 2000-2017, PBS patients were recruited to our prospective PBS study and medical records were cross-sectionally analyzed, generating individualized RUBACE scores. We designed the pragmatic RUBACE scoring system based on six sub-scores (R: renal, U: ureter, B: bladder/outlet, A: abdominal wall, C: cryptorchidism, E: extra-genitourinary, generating the acronym RUBACE), yielding a potential summed score of 0-31. The E score was utilized to segregate syndromic PBS and PBS-plus variants. The cohort was scored per classic Woodard criteria and RUBACE scores compared to Woodard category.</p>
</sec>
<sec id="S3">
<title>RESULTS:</title>
<p id="P3">48 males and two females had mean RUBACE scores of 13.8 (range: 8-25) at a mean age of 7.3 years. Segregated by phenotypic categories, there were 39 isolated PBS (76%), 6 syndromic PBS (12%) and 5 PBS-plus (10%) cases. Mean RUBACE scores for Woodard categories 1, 2 and 3 were 20.5 (n=8), 13.8 (n=25), and 10.6 (n=17), respectively (p&lt;0.001).</p>
</sec>
<sec id="S4">
<title>CONCLUSIONS:</title>
<p id="P4">RUBACE is a practical, organ/system level, phenotyping tool designed to grade PBS severity and categorize patients into isolated PBS, syndromic PBS, and PBS-plus groups. This standardized system will facilitate genotype-phenotype correlations and future prospective multicenter studies assessing medical and surgical treatment outcomes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Prune Belly Syndrome</kwd>
<kwd>Cryptorchidism</kwd>
<kwd>Severity Score</kwd>
<kwd>Megacystis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>